{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/7135461",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/526155201"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#7135461",
  "code": "3B64.12",
  "source": "http://id.who.int/icd/entity/7135461",
  "classKind": "category",
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/7135461/postcoordinationScale/associatedWith",
      "axisName": "http://id.who.int/icd/schema/associatedWith",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "AllowAlways",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/1868408442",
        "http://id.who.int/icd/release/11/2024-01/mms/1583926619",
        "http://id.who.int/icd/release/11/2024-01/mms/1323892810"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Drug-induced thrombocytopenic purpura"
  },
  "definition": {
    "@language": "en",
    "@value": "Thrombocytopenic purpura attributable to drug toxicity (e.g. cytotoxic chemotherapeutic or immunosuppressive agents) or to an idiosyncratic drug-associated allergic thrombocytopenia (e.g. quinine, thiazides)."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced thrombocytopenic purpura"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced immune thrombocytopenia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1910746507"
    },
    {
      "label": {
        "@language": "en",
        "@value": "medicament-induced immune thrombocytopenia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1910746507"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced non-immune thrombocytopenia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1960280693"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Heparin-induced thrombocytopenia"
      },
      "foundationReference": "http://id.who.int/icd/entity/1143142333"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Heparin-induced thrombosis/thrombocytopenia syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1143142333"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Heparin skin necrosis due to immune heparin-induced thrombocytopenia"
      },
      "foundationReference": "http://id.who.int/icd/entity/468742411"
    },
    {
      "label": {
        "@language": "en",
        "@value": "HITTS - [Heparin-induced thrombocytopenia and thrombosis syndrome]"
      },
      "foundationReference": "http://id.who.int/icd/entity/468742411"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Heparin-induced thrombocytopenia, Type 1"
      },
      "foundationReference": "http://id.who.int/icd/entity/728795479"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Heparin-induced thrombocytopenia, Type 2"
      },
      "foundationReference": "http://id.who.int/icd/entity/1420710618"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Drug-induced thrombocytopenic purpura specified as refractory"
      },
      "foundationReference": "http://id.who.int/icd/entity/197919200"
    }
  ]
}